Skip to content
Menu

RedHill Biopharma Ltd. RDHL

Full chart Compare
Set alert

Price alert · RDHL

All alert types
0.38 USD -0.01 (-1.60%)

Regular-session close

0.38 +0.01 +1.41%

After hours · Nov 13, 5:52 PM ET

0.37 Day range 0.3926
0.366 52-week range 1.40
YTD
-63.59%
1 year
-64.95%

RDHL revenue history

Revenue is income from the company’s ordinary business activities.

286,000 USD

FY 2025 · Period ended

Coverage: complete. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

FY 2010: 0USDFY 2011: 23,000USDFY 2012: 16,000USDFY 2013: 12,000USDFY 2014: 7,014,000USDFY 2015: 3,000USDFY 2016: 101,000USDFY 2017: 4,007,000USDFY 2018: 8,360,000USDFY 2019: 6,291,000USDFY 2020: 64,359,000USDFY 2021: 85,757,000USDFY 2022: 61,800,000USDFY 2023: 0USDFY 2024: 0USDFY 2025: 286,000USD

Scroll the table to see all values →

Revenue · annual · USD
Fiscal periodPeriod endRevenueYoY changeYoY %
FY 20252025-12-31286,000286,000Not meaningful
FY 20242024-12-3100Not meaningful
FY 20232023-12-310-61,800,000-100.00%
FY 20222022-12-3161,800,000-23,957,000-27.94%
FY 20212021-12-3185,757,00021,398,00033.25%
FY 20202020-12-3164,359,00058,068,000923.03%
FY 20192019-12-316,291,000-2,069,000-24.75%
FY 20182018-12-318,360,0004,353,000108.63%
FY 20172017-12-314,007,0003,906,0003867.33%
FY 20162016-12-31101,00098,0003266.67%
FY 20152015-12-313,000-7,011,000-99.96%
FY 20142014-12-317,014,0007,002,00058350.00%
FY 20132013-12-3012,000-4,000-25.00%
FY 20122012-12-3116,000-7,000-30.43%
FY 20112011-12-3123,00023,000Not meaningful
FY 20102010-12-310Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-10-03T06:01:43.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.